Response Rates as Predictors of Overall Survival: A Meta-Analysis of Acute Myeloid Leukemia Trials
Open Access
- 1 January 2017
- journal article
- review article
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 8 (9) , 1562-1567
Abstract
Background: Response rates such as overall response rate (ORR), complete response (CR) and complete response with incomplete blood recovery (CRi) can be evaluated in a much shorter period of time, potentially accelerating decision making during drug development. The objective of this work was to evaluate the relationship between ORR, CR, CRi or better (CRi+CR) rates and median overall survival (OS) to determine whether response rates could be used as predictors of median OS in acute myeloid leukemia (AML).Keywords
This publication has 16 references indexed in Scilit:
- Azacitidine in untreated acute myeloid leukemia: A report on 149 patientsAmerican Journal of Hematology, 2014
- Clinical Trial Evidence Supporting FDA Approval of Novel Therapeutic Agents, 2005-2012JAMA, 2014
- Clofarabine doubles the response rate in older patients with acute myeloid leukemia but does not improve survivalBlood, 2013
- Gemtuzumab ozogamicin in acute myeloid leukemia: a remarkable saga about an active drugBlood, 2013
- The addition of gemtuzumab ozogamicin to low-dose Ara-C improves remission rate but does not significantly prolong survival in older patients with acute myeloid leukaemia: results from the LRF AML14 and NCRI AML16 pick-a-winner comparisonLeukemia, 2012
- Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid LeukemiaJournal of Clinical Oncology, 2012
- Accelerated Approval of Oncology Products: The Food and Drug Administration ExperienceJNCI: Journal of the National Cancer Institute, 2011
- Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid LeukemiaJournal of Clinical Oncology, 2010
- End points to establish the efficacy of new agents in the treatment of acute leukemiaBlood, 2006
- The effect of chemotherapy on acute leukemia in the humanJournal of Chronic Diseases, 1961